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Maternal consumption of fish oil
programs reduced adiposity in
broiler chicks
Ronique C. Beckford1, Sarah J. Howard1, Suchita Das1, Abigail T. Farmer2, Shawn R.
Campagna2, Jiali Yu3, Robert L. Hettich3,4, Jeanna L. Wilson5 & Brynn H. Voy 1,3
Maternal intake of eicosapentaenoic acid (EPA; 20:5 n-3) and docosahexaenoic acid (22:6 n-3) has
been associated with reduced adiposity in children, suggesting the possibility to program adipose
development through dietary fatty acids before birth. This study determined if enriching the maternal
diet in fish oil, the primary source of EPA and DHA, affected adipose development in offspring. Broiler
chickens were used because they are obesity-prone, and because fatty acids provided to the embryo
can be manipulated through the hen diet. Hens were fed diets supplemented (2.8% wt:wt) with corn oil
(CO; n-6) or fish oil (FO; n-3) for 28 d. Chicks from both maternal diet groups were fed the same diet after
hatch. Maternal FO consumption enriched chick adipose tissue in EPA and DHA and reduced adiposity
by promoting more, but smaller, adipocytes. This adipocyte profile was paralleled by upregulated
expression of the adipogenic regulator PPARG and its co-activator PPARGC1B, and reduced expression
of LPL. Proteomics identified 95 differentially abundant proteins between FO and CO adipose tissue,
including components of glucose metabolism, lipid droplet trafficking, and cytoskeletal organization.
These results demonstrate that the maternal dietary fatty acid profile programs offspring adipose
development.
Active proliferation and differentiation of preadipocytes shortly before birth and in the first few years of life creates a sensitive window for adipose development1–3. Consequently, the maternal diet and in utero environment
can impact adipose deposition and the consequent risk for obesity. Adipose tissue is subject to developmental
programming, in which exposures in utero exert lasting effects on tissue phenotypes. Variations in the maternal
diet, lifestyle and environmental exposures have been linked to increased adiposity later in life through stable
effects on adipocyte growth and metabolism4–6. Programming of adipose tissue is of particular public health
interest because obesity, which is epidemic in the U.S. and globally, begins early in life. Approximately 27% of
children in the U.S. are overweight or obese by age five7. Obese children are much more likely to be obese as adults
when compared to normal weight children8,9. Therefore, limiting excess fat accumulation in the first few years of
life is an important tool for the prevention of adult obesity. Evidence that adiposity at birth predicts fatness later
in childhood highlights the need to understand prenatal factors that influence adipose development10,11.
The types of fatty acids provided in the maternal diet may influence early adipose development and the
resultant propensity for fat accumulation in children. In vitro studies with adipocyte cell lines demonstrate that
polyunsaturated fatty acids (PUFAs) of the n-3 and n-6 series differentially regulate preadipocyte proliferation,
adipogenesis, and triglyceride storage. Omega-6 PUFAs, particularly arachidonic acid (AA; 20:4 n-6) tend to be
pro-adipogenic12–14, while LC n-3 PUFAs (e.g., eicosapentaenoic acid (EPA; 20:5 n-3) and docosahexaenoic acid
(DHA; 22:6 n-3) attenuate lipid accumulation and promote an oxidative adipocyte phenotype15–17. Fatty acid profiles of diets in the US and other industrialized countries have shifted over the last several decades to favor consumption of n-6 PUFAs at the expense of n-3 PUFAs18. Both fatty acids supplied to the developing embryo and
the fatty acid profiles of breast milk directly reflect the maternal diet19, creating the potential to impact the earliest
stages of adipose development. Epidemiological attempts to associate maternal dietary fatty acid profiles with fat
mass in children have been inconclusive. Two recent prospective studies demonstrated an inverse relationship
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FO/CO ratio
PC species

Brain

Liver

PC (38:10)

7.40

130

PC (36:5)

13.9

13.9

PC (34:5)

21.5

11.1

PC (42:11)

11.4

6.62

PC (34:6)

4.98

4.79

PC (38:8)

6.29

4.76

PC (44:12)

1.65

4.01

PC (40:6)

1.19

2.51

PC (38:7)

2.16

2.43

PC (36:6)

1.85

2.09

PC (40:9)

2.41

1.71

Table 1. Enrichment of brain and liver phospholipids at hatch in broiler chicks produced from hens fed diets
containing CO or FO for 28 d. FO/CO ratio was calculated from the relative abundance of each species in brain
and liver to qualitatively evaluate tissue enrichment immediately after hatch, using N = 2 per tissue and diet
group; CO, corn oil; FO, fish oil.
between levels of n-3 PUFAs in maternal blood during pregnancy and fatness in childhood20,21. However, relative
contributions of the pre- and perinatal maternal diet are difficult to separate from shared consumption patterns
after lactation in human studies.
Avians provide a unique model in which to specifically manipulate the pool of fatty acids that are supplied to
the embryo and test the effects on adipose deposition after hatch (i.e. birth). The yolk provides the majority of
fatty acids to developing tissues in the embryo, and for one to two days after hatch, until feeding is established.
The fatty acid profile of the yolk can be modified through the source of dietary fat provided to the hen22,23. For
example, commercial eggs that are enriched in EPA and DHA are produced by supplementing the hen’s diet with
marine oils. We used this relationship to test the hypothesis that enriching the embryo in EPA and DHA, supplied
in fish oil (FO), reduces adipose deposition in chicks. Corn oil (CO) was used as a reference because it contains a
comparable level of PUFA (~ 60%), but primarily those of the n-6 family. All chicks were fed a CO-based diet after
hatch to confine the experimental manipulation to the period of embryonic development. We demonstrate that
maternal FO feeding significantly reduced adiposity after hatch, with no effect on growth. Our results suggest that
fatty acids in the maternal diet contribute to developmental programming of adipose tissue.

Results

Egg production and chick tissue fatty acid composition. Hatchability, egg weights, and chick weight

at hatch were used to assess the effect of hen diet on egg quality, none of which differed significantly between
eggs from CO and FO hens (P > 0.05). The fatty acid compositions of phospholipids contained in brain and liver
were profiled and qualitatively compared to confirm that EPA and DHA were enriched in tissues of FO chicks,
compared to CO chicks, at hatch. Brain and liver were used because of their relative mass at hatch. Enrichment
levels of phosphatidylcholine (PC) species containing EPA and DHA are shown in Table 1. The fold-increase (FO/
CO) ranged from ~ 1.2 (18:0/22:6 in brain) to ~ 130.4 (PC 18:4/22:6 in liver), with greater than 2-fold enrichment
for most species. These data confirm that the maternal dietary fatty acid profile was reflected in tissue fatty acid
composition of the resultant chicks at the time of hatch.
The effect of maternal fatty acid source on the fatty acid composition of developing adipose tissue was quantified using GC-FID. Fatty acid composition of the total lipid fraction of abdominal adipose tissue was analyzed at
7 and 14 d of age (Table 2). Tissue abundance of five fatty acids (palmitoleic, γ-linolenic, eicosenoic, eicosadienoic
and docosadienoic acids) increased with age (PAge < 0.05) but was not affected by diet or diet X age interactions.
Adipose tissue of FO chicks was significantly enriched in EPA and DHA (PDiet < 0.01). At 7 d, tissue from FO
chicks contained approximately six times more EPA than tissue from CO chicks. Enrichment declined from 7 to
14 d as all chicks consumed a CO-based diet (PAge*Diet < 0.01), but still differed by ~ 2-fold. Comparable effects
were seen for DHA content, which was increased by ~ 2.5-fold at 7 d and ~ 1.8-fold at 14 d. As for EPA, the relative enrichment declined with age (PAge*Diet = 0.03), and did not differ significantly at 14 d. Fatty acid composition
of PC species in abdominal adipose tissue at 7 d also reflected the maternal diet. Six species containing EPA or
DHA were significantly increased, by 3- to 4-fold, in FO vs. CO tissue (Supplemental Table 1).

Body weight and adipose deposition.

Subcutaneous adipose tissue in chickens develops in the embryo
and is visible at hatch, while the abdominal depot develops in the first few days after hatch. Weights of both depots
were measured to assess the effect of FO in the maternal diet on offspring fat deposition. Body weights did not
differ significantly between CO and FO chicks at either 7 or 14 d (Table 3). Food intake did not differ between CO
and FO chicks (data not shown). Maternal fatty acid source regulated adiposity of both depots in an age-specific
manner. At 7 d, subcutaneous and abdominal adiposity did not differ significantly between FO and CO chicks
(P > 0.05). However, relative weights of both depots were significantly reduced in FO vs. CO chicks (P < 0.05) at
14 d. On average, FO reduced adiposity by ~ 38% in each of the two depots. Effects of maternal diet on adiposity
were not associated with diet-induced differences in glycemia or lipolysis, as plasma glucose and NEFA levels
were comparable between treatments at both ages (Table 3). The effects of maternal FO on abdominal adipose
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CO

P-value

FO

Fatty acid (mol %)

7d

14 d

7d

14 d

SEM

Diet

Age

Diet × Age

Capric, 10:0

0.007

0.007

0.005

0.009

0.001

0.28

0.45

0.28

Lauric, 12:0

0.024

0.020

0.024

0.027

0.002

0.13

0.81

0.13

Myristic, 14:0

0.520

0.462

0.555

0.577

0.031

0.06

0.70

0.21

Myristoleic, 14:1

0.144

0.154

0.152

0.195

0.015

0.13

0.11

0.31

Pentadecanoic, 15:0

0.058

0.056

0.060

0.054

0.007

0.10

0.61

0.77

Palmitic, 16:0

22.4

22.1

23.4

28.9

1.92

0.61

0.20

0.15

Palmitoleic, 16:1

5.17

6.09

5.61

7.94

0.610

0.08

0.01

0.27

Heptadecanoic, 17:0

0.096

0.081

0.095

0.085

0.006

0.94

0.33

0.83

Stearic, 18:0

5.72

5.03

5.43

6.38

0.509

0.49

0.87

0.29

Oleic, 18:1

30.7

30.0

31.2

18.2

4.36

0.21

0.14

0.17

Linoleic, 18:2n-6 cis

16.5

17.2

15.9

18.0

1.37

0.99

0.39

0.55

Linoleladic,18:2n-6 trans

16.5

16.8

15.6

17.6

1.78

0.99

0.39

0.55

γ-Linolenic 18:3n-6

0.180

0.206

0.164

0.209

0.015

0.68

0.03

0.55

α-Linolenic, 18:3n-3

0.718

0.672

0.689

0.722

0.067

0.88

0.92

0.56

Arachidic, 20:0

0.052

0.056

0.052

0.071

0.006

0.26

0.11

0.30

Eicosenoic, 20:1n-9

0.289

0.367

0.280

0.439

0.027

0.27

<0.01

0.16

Eicosadienoic, 20:2n-6

0.134

0.155

0.137

0.169

0.010

0.45

0.03

0.60

Eicosatrienoic, 20:3n-3

0.131

0.142

0.143

0.166

0.001

0.12

0.15

0.60

Dihomo- γ-Linolenic, 20:3n-6 0.205

0.189

0.145

0.145

0.001

0.07

0.78

0.77

Eicosapentaenoic, 20:5n-3

0.009b

0.010b

0.060a

0.02a

0.005

<0.01

<0.01

<0.01

Arachidonic, 20:4n-6

0.014

0.012

0.009

0.009

0.001

0.69

0.06

0.53

Erucic, 22:1n-9

0.015

0.013

0.014

0.016

0.001

0.29

1.00

0.20

Docosadienoic, 22:2n-6

0.031

0.037

0.031

0.043

0.003

0.29

<0.01

0.36

Tricosanoic, 23:0

0.050

0.035

0.030

0.029

0.006

0.045

0.20

0.25

Docosahexaenoic, 22:6n-3

0.036b

0.016b

0.092a

0.028b

0.007

<0.01

<0.01

0.03

Nervonic, 24:1n-9

0.017

0.006

0.008

0.008

0.004

0.39

0.17

0.20

SCD-16

0.226

0.286

0.240

0.282

0.028

0.85

0.08

0.75

SCD-18

5.41

7.47

5.90

3.68

1.32

0.23

0.95

0.12

D6D

0.006

0.01

0.004

0.010

0.002

0.57

0.01

0.57

DNL

0.683

0.646

0.753

0.084

0.132

0.11

0.91

0.50

EL

0.260

0.220

0.232

0.216

0.019

0.40

0.15

0.53

Activity index3

Table 2. Abdominal adipose tissue fatty acid content of broiler chicks produced from hens fed diets containing
CO or FO for 28 d. Fatty acid content of abdominal adipose tissue, represented as mol%. Values are means
from N = 5 per diet and age group (7 d and 14 d). SEM values are the pooled SEM across groups; CO, corn oil;
FO, fish oil. P-values are from ANOVA F-tests for main effects of diet, age and their interaction (diet × age).
Labeled means are from post-hoc comparisons using LSM, calculated following a significant ANOVA F-test for
diet × age interaction. Those in a row without a common letter differ; P < 0.05. Indices of enzyme activities were
calculated from mol%, using the following equations: SCD (Stearoyl-CoA desaturase)-16 (16:1n-7/16:0); SCD18 (18:1n-9/18:0); D6D (Delta-6 desaturase) (18:3n-6/18:2n-6); DNL (De novo lipogenesis) (16:0/18:2n-6); EL
(Elongation) (18:0/16).

tissue were further explored because this is the depot in which broilers primarily deposit excess fat. Adipocyte
size was measured in H&E-stained sections of abdominal adipose tissue to determine if fatness between groups
differed due to cellular hypertrophy (Fig. 1). As expected, adipocyte size increased from 7 to 14 d, reflecting the
rapid increase in fat deposition (Fig. 1E). Average cell size did not differ between FO and CO at 7 d (P = 0.21) but
was significantly reduced in FO at 14 d (P = 0.03). Adipocyte number (Fig. 1F), calculated based on adipocyte
volume and adipose mass, showed a corresponding significant increase in FO vs. CO chicks at 14 (P = 0.03) but
not 7 d of age (P = 0.12). Analysis of the adipocyte size distribution revealed that FO favored the abundance of
small adipocytes, while there was a greater frequency of larger adipocytes in the CO chicks (Fig. 2). At 7 d there
was a significantly lower percentage of adipocytes in three of the larger bin sizes in the FO chicks (P < 0.05;
Fig. 2A). This effect persisted at 14 d with approximately a 3-fold difference between FO and CO in the percentage
of adipocytes (P = 0.02) in the largest bin (Fig. 2B). Conversely, approximately 66% of FO adipocytes were in the
two smallest bins, compared to 49% in CO.

QPCR.

Potential mechanisms for the difference in adiposity were evaluated based on expression of genes that
mediate fatty acid metabolism and adipogenesis. As shown in Fig. 3A, adipose tissue from FO chicks expressed
significantly higher levels of peroxisome proliferator activated receptor gamma (PPARG; 4.4-fold) and its
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CO

P-value

FO

7d

14 d

7d

14 d

SEM

Diet

Age

Hatch body wt (g)

41.6

41.6

40.6

38.5

1.04

0.06

0.31

Diet × Age
0.33

Final body wt (g)

123b

241a

111b

303a

26.7

0.35

< 0.01

0.18

Abdominal

0.34c

1.21a

0.31c

0.75b

0.11

0.04

< 0.01

0.06

Subcutaneous

0.91

1.23a

0.85b

0.74b

0.8

0.02

0.38

0.08

Glucose (mg/dL)

276

303

346

314

92.3

0.29

0.56

0.20

NEFA (mM)

0.57

0.65

0.61

0.64

0.27

0.85

0.49

0.80

Adiposity (%)
ab

Table 3. Effect of dietary enrichment on performance and serum metabolites of broiler chicks produced from
hens fed diets containing CO or FO for 28 d. Values are means from N = 10 per diet and age group (7 d and 14
d). SEM values are the pooled SEM across groups; CO, corn oil; FO, fish oil. P-values are from ANOVA F-tests
for main effects of diet, age and their interaction (diet x age). Labeled means are from post-hoc comparisons
using LSM, calculated following a significant ANOVA F-test. Labeled means in a row without a common letter
differ; P < 0.05. Adiposity = (depot weight/body weight) × 100

coactivator PPARGC1B (PPARG coactivator 1 β; 3.4-fold) than tissue from CO chicks (P < 0.05). Conversely,
expression of lipoprotein lipase (LPL) was approximately 60% lower in adipose tissue from FO vs. CO (P < 0.05).
Expression of carnitine palmitoyltransferase 1 (CPT1; mitochondrial fatty acid oxidation), acyl-coenzyme A oxidase 1 (ACOX1; peroxisomal fatty acid oxidation), and fatty acid synthase (FASN; de novo lipogenesis) did not
differ significantly between groups (Fig. 3B; P > 0.05). Liver is the primary site of de novo lipogenesis in avians (as
in humans)24 and plays an important role in fat deposition in broiler chickens25. Diet did not significantly affect
expression of CPT1, ACOX1 and FASN in liver (Fig. 3C), consistent with comparable hepatic triglyceride content
in FO and CO chicks (data not shown).

Adipose proteomics.

The proteomes of adipose tissue from FO and CO chicks were analyzed by LC-MS/
MS and compared to identify additional pathways that were altered by maternal FO feeding. A total of 95 known
proteins differed significantly (P < 0.05) between FO and CO chicks (Table 4). Functional enrichment analysis
revealed that this set of proteins was enriched (adj. P < 0.05) for components of cytoskeletal organization and
cellular tight junctions, and for proteins involved in glycolysis and gluconeogenesis (Table 5). Proteins associated
with the cytoskeleton (e.g., actins, vimentin (VIM), tubulins) were more abundant in FO vs. CO adipose tissue.
Maternal FO also increased levels of the adipocyte lipid droplet protein perilipin (PLIN1) and Ras-related protein
Rab-18 (RAB18; both ~ 1.9-fold, FO/CO), although these changes did not meet the criterion for statistical significance (P = 0.051 and 0.053, respectively). Glycolytic proteins were downregulated by maternal FO. Fructose-1,
6-bisphosphatase 1 and 2 (FBP1 and FBP2), pyruvate kinase (PK), enolase 3 (ENO3), and phosphoenolpyruvate
carboxykinase 2 (PCK2) were significantly less abundant in tissue of FO vs. CO chicks. Two fatty acid binding
proteins, fatty acid binding protein1 (FABP1) and liver basic fatty acid binding protein (LBFABP), were also present at significantly lower levels in FO adipose tissue. Functional enrichment indicated that proteins involved in
muscle development and filament structure differed between FO and CO chicks.

Discussion

The very early onset of obesity in children highlights the need to understand how the maternal diet and lifestyle
influence adipose accumulation after birth. This study fills a gap in knowledge by demonstrating that the types
of fatty acids supplied to the developing embryo before birth influence adipose development. More specifically,
enriching the maternal diet in FO reduced chick adiposity when compared to a maternal diet based on CO. All
chicks were fed a CO-based diet after hatch, restricting the dietary manipulation to the period prior to hatch. The
feeding protocol that we used was developed to enrich eggs for the consumer market in DHA and EPA. Although
we did not measure yolk fatty acids, we did find marked enrichment of EPA and DHA in liver and brain phospholipids at hatch, indicating diet enriched the developing embryo as expected.
Attempts to retrospectively link fatty acid content of the maternal diet to child adiposity in humans have been
inconclusive26. These types of studies are limited by reliance on BMI, which is a coarse index of adiposity in children, and on dietary recall to assess fatty acid intake. However, recent prospective studies using more sensitive
measures of body composition and of fatty acid status have demonstrated an inverse relationship between maternal AA relative to EPA and DHA (AA/DHA + EPA) and childhood adiposity. A study of 227 mother-child pairs
revealed that AA/DHA + EPA in maternal circulation mid-pregnancy predicted adiposity in children at three
years of age27. In a much larger study 4,830 mother-child pairs, mid-pregnancy levels of EPA, DHA and docosapentaenoic acid (22:5 n-3) were associated with lower percentages of body fat and abdominal fat in children at a
median age of six years20. Likewise, maternal levels of n-6 PUFA were associated with increased childhood adiposity. The ratio of AA/DHA + EPA in transitional breast milk, which reflect dietary patterns in the previous 90
days, was also recently shown to predict body fat percentage at four months of age28. Interestingly, none of these
studies found a significant relationship with body weight or BMI, just as we found no effect of maternal FO feeding on chick body weight or growth, suggesting specific effects on adipose tissue. Each of these studies profiled
fatty acids in the maternal blood, which provides a sensitive assessment of intake during pregnancy. However
those levels may not completely reflect fatty acid delivery to the embryo, which also depends upon transfer across
the placenta29. They also may be confounded by the child’s dietary intake after birth and lactation, particularly
SCieNTifiC ReporTS | 7: 13129 | DOI:10.1038/s41598-017-13519-5
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Figure 1. Adipocyte volume and number in CO and FO chicks at 7 and 14 d of age. Representative H&Estained images of abdominal adipose tissue from CO (A,B) and FO (C,D) used to determine adipocyte volume
at 7 (A,C) and 14 (B,D) d are shown. Scale bar = 40 μm. Two slides, and three independent fields per slide, were
counted in three chicks in each age/diet group. (E) Average adipocyte volume (μm3 × 104), ±SD; (F) average
adipocyte number (X 106), ±SD. Main effects of diet, age and their interaction (diet × age) on adipocyte volume
and number were determined by ANOVA. Significant F-tests (P < 0.05) for diet × age interaction were followed
by post-hoc comparisons made using LSM. *Different from CO, P < 0.05; CO, corn oil; FO, fish oil.

those that measured adiposity a few years after birth. Our findings complement these studies by demonstrating
that fatty acids provided during embryonic development alone are sufficient to alter adiposity.
The shift towards increased small adipocytes coupled with upregulated expression of PPARG and its coactivator PPARGC1B suggest that maternal FO promoted adipogenesis, despite reducing adiposity. EPA and DHA
can act as ligands to activate PPARG, which would be expected to promote adipogenesis through this nuclear
receptor’s role in orchestrating adipocyte differentiation. However, in vitro studies have shown both pro-and
anti-adipogenic effects of EPA and DHA, which may be due to variation in cell lines, differentiation protocols,
reference treatments, and fatty acid concentrations30–32. Interestingly, a shift towards increased frequency of small
SCieNTifiC ReporTS | 7: 13129 | DOI:10.1038/s41598-017-13519-5
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Figure 2. Frequency distributions of adipocyte area (μm2) of CO and FO chicks at 7 (A) and 14 (B) d of age.
Adipocyte areas were measured from H&E-stained images and divided into bins by size. Average frequencies
of cells within each bin, ± SD, are shown and were compared by T-test. *Different from CO, P < 0.05; #different
from CO, P < 0.10, FO vs. CO; CO, corn oil; FO, fish oil.

adipocytes and increased expression of PPARG has been described in fat-1 mice, which endogenously synthesize
n-3 PUFA due to transgenic expression of a novel fatty acid desaturase from C. elegans33. Microarray data indicated that constitutive synthesis of n-3 PUFAs within adipocytes of fat-1 mice markedly suppressed expression of
GATA binding protein 3, which normally inhibits the progression of preadipocytes into differentiation by directly
suppressing PPARG34.
Reduced availability of glycerol-3-phosphate and fatty acids for triacylglycerol synthesis may have restricted
hypertrophy of FO adipocytes. Esterification of fatty acids into triacylglycerol requires a steady supply of
glycerol-3-phosphate. In adipose tissue, this is synthesized during glycolytic metabolism of glucose, and from
pyruvate through glyceroneogenesis35,36. Levels of several glycolytic proteins and of PEPCK, which is rate-limiting
for glyceroneogenesis, were reduced in FO vs. CO adipose tissue. In chickens (and humans) the majority of
stored fatty acids are delivered to adipose tissue from the liver. Lipoprotein lipase, which cleaves fatty acids from
circulating lipoproteins, was also down-regulated in FO adipose tissue. In combination, these effects suggest
that maternal FO may have reduced adipocyte size, at least in part, by attenuating the capacity to extract, esterify
and store fatty acids as triacylglycerol. Whether this is a primary effect of maternal FO or a secondary response
to reduced delivery of fatty acids from liver cannot be determined, as we did not measure plasma VLDL levels.
However, hepatic lipogenesis (based on expression of FASN) and triglyceride content (data not shown) did not
differ between FO and CO, suggesting that diet did not alter the supply of fatty acids from liver.
A growing body of literature illustrates that the structural assembly of lipid droplets influences lipid metabolism in adipocytes. Maternal FO feeding increased the abundances of three proteins, PLIN1, VIM and RAB18,
which localize to the surface of adipocyte lipid droplets and play key roles in balancing lipid storage and mobilization. Perilipin1 is the major surface protein of adipocyte lipid droplets, where it orchestrates lipolysis by
controlling access of lipase enzymes to triacylglycerol molecules37–39. Vimentin is an intermediate filament that
scaffolds lipid droplets to maintain their individual structural integrity40. Ras-related protein Rab-18 facilitates
exchange of lipids between lipid droplets and the endoplasmic reticulum, playing roles in both lipolysis and
lipogenesis41,42. All three proteins are critical for the physical remodeling and trafficking that are necessary for
storage and mobilization of lipids. The physiological significance of increased levels of VIM, PLIN1 and RAB18
in FO adipose tissue requires further study, but the roles of each protein and their interactions in lipid mobilization suggests that this response may facilitate lipid utilization within adipocytes. Consistent with this possibility,
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Figure 3. Expression of genes involved in adipogenesis, fatty acid oxidation and uptake of fatty acids in
abdominal adipose tissue and liver of CO and FO chicks at 14 d. Expression of each gene of interest in adipose
tissue (A,B) and liver (C) was normalized to that of TBC1D8, used a reference gene. Data shown are average
relative expression values, ± SD, N = 5–6/diet group. Expression levels between CO and FO for each gene
were compared using T-test. *Different from CO, P < 0.05. ACOX1, Acyl-CoA oxidase 1; CPT1, Carnitine
palmitoyltransferase 1; PPARG, Peroxisome proliferator-activated receptor gamma; PPARGC1B, Peroxisome
proliferator-activated receptor gamma co-activator 1 Beta; FASN, Fatty acid synthase; LPL, Lipoprotein lipase;
CO, corn oil; FO, fish oil.
overexpression of PLIN1 was shown to induce fatty acid oxidation in white adipocytes43. Follow-on studies are
prompted to determine how maternal FO influences adipocyte architecture and if this contributes to the reduction in adiposity.
The mechanisms through which maternal consumption of LC n-3 PUFA can reduce adiposity in offspring
remain to be determined. Transcriptional control through PPARs by EPA, DHA and their metabolites would
require sustained enrichment of those fatty acids within adipose tissue. Fatty acid profiling demonstrated that
the total lipid pool of FO chicks was enriched in both EPA and DHA up to 14 d, although the fold-enrichment
relative to the CO group decreased between weeks one and two. How long this enrichment persists, especially
when the post-hatch diet is not supplemented with FO, remains to be determined. Epigenetic modifications of
genes involved in adipose deposition may also underlie reduced adiposity in FO chicks. In a recent randomized,
controlled clinical study, fish oil supplementation during pregnancy was shown to differentially methylate 21
chromosomal regions at birth, with some differences persisting to five years of age44. Circulating DHA levels,
both early in pregnancy and at birth, were significantly correlated with methylation of PPAR-α in infants45, indicating the potential for epigenetic programming of lipid metabolism. Interestingly, abundance of Apolipoprotein
B mRNA editing enzyme catalytic subunit 2 (APOBEC2), was markedly reduced (~ 16-fold) in FO vs. CO adipose tissue, according to our proteomics data. This enzyme is part of a coordinated DNA demethylase system
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Increased (FO/CO)

FO/CO ratio P-value2

Protein symbol Protein name

4.20

0.017

EPB41L1

erythrocyte membrane protein band 4.1-like 1

3.49

0.002

VIM

vimentin

3.24

0.023

HBAA

hemoglobin alpha, subunit A

3.04

0.000

TBA1

tubulin alpha-1 chain

3.01

0.024

ANK1

ankyrin 1, erythrocytic

2.97

0.034

NFASC

neurofascin

2.71

0.001

DST

dystonin

2.69

0.001

FMO3

dimethylaniline monooxygenase [N-oxide-forming]

2.69

0.000

ACTG1

actin, gamma 1

2.65

0.000

ACTB

actin, beta

2.64

0.001

TBB7

tubulin beta-7 chain

2.63

0.000

ACT5

actin, cytoplasmic type 5

2.62

0.042

COL28A1

collagen, type XXVIII, alpha 1

2.55

0.022

SPTB

spectrin, beta, erythrocytic

2.55

0.001

ALB

albumin

2.49

0.011

A2ML2

alpha-2-macroglobulin-like 2

2.44

0.012

ITIH2

inter-alpha-trypsin inhibitor heavy chain 2

2.40

0.046

IGF2R

insulin like growth factor 2 receptor

2.29

0.028

BDH1

3-hydroxybutyrate dehydrogenase, type 1

2.16

0.035

FBLN1

fibulin 1

2.12

0.008

TUBA3

tubulin alpha-3 chain-like

2.01

0.042

PELO

pelota homolog

2.00

0.051

PLIN1*

perilipin 1

1.98

0.054

RAB18*

ras-related protein Rab-18

1.88

0.017

RBP4

retinol-binding protein 4

1.85

0.017

ANXA5

annexin A5

1.83

0.003

TMED7

transmembrane emp24 protein transport domain containing 7

1.79

0.003

TF

transferrin

1.78

0.054

VDAC3

voltage dependent anion channel 3

1.70

0.024

TUBAL3

tubulin alpha like 3

1.69

0.002

TUBB4B

tubulin beta 4B class IVb

1.69

0.007

TUBA3E

tubulin alpha 3e

1.65

0.010

TUBA4B

tubulin alpha 4b

1.63

0.024

PLA2G6

phospholipase A2 group VI

1.61

0.034

NSF

N-ethylmaleimide sensitive factor, vesicle fusing ATPase

1.57

0.032

ERAP1

endoplasmic reticulum aminopeptidase 1

1.54

0.034

DNM1L

dynamin 1 like

1.53

0.003

TBB3

tubulin beta-3 chain

1.52

0.007

USP9X

ubiquitin specific peptidase 9, X-linked

1.50

0.043

PIT54

PIT54 protein

0.56

0.020

TXN

thioredoxin

0.51

0.046

HMGCL

3-hydroxymethyl-3-methylglutaryl-CoA lyase

0.45

0.019

PKM

pyruvate kinase, muscle

0.44

0.031

TNX

avian tenascin X

0.41

0.045

LAMA5

laminin, alpha 5

0.38

0.024

PPA2

pyrophosphatase

0.33

0.008

FXR1

fragile X mental retardation, autosomal homolog 1

0.33

0.034

GIF

gastric intrinsic factor

0.31

0.033

NT5C2

5′-nucleotidase, cytosolic II

0.31

0.033

NT5C3

cytosolic purine 5′-nucleotidase

0.31

0.014

FBP1

fructose-1,6-bisphosphatase 1

0.28

0.050

UQCRFS1

ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1

0.25

0.039

LBFABP

liver basic fatty acid binding protein

0.22

0.032

ATP2A3

ATPase, Ca++ transporting, ubiquitous

0.21

0.008

MYH1G

myosin, heavy chain 1 G, skeletal muscle

0.20

0.009

CKM

creatine kinase, muscle

Decreased
(FO/CO)

Continued
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FO/CO ratio P-value2

Protein symbol Protein name

0.20

0.009

MYH1C

myosin, heavy chain 1 C, skeletal muscle

0.20

0.006

MYL1

myosin, light chain 1, alkali; skeletal, fast

0.19

0.021

PCK2

phosphoenolpyruvate carboxykinase 2

0.18

0.004

MYH1B

myosin, heavy chain 1B, skeletal muscle

0.17

0.003

MYH1F

myosin, heavy chain 1 F, skeletal muscle

0.17

0.020

MYL3

myosin, light chain 3, alkali; ventricular, skeletal, slow

0.17

0.006

CRYAB

crystallin, alpha B

0.17

0.005

MYSS

myosin heavy chain, skeletal muscle

0.15

0.005

MYH1E

myosin, heavy chain 1E, skeletal muscle

0.15

0.003

MYH1D

myosin, heavy chain 1D, skeletal muscle

0.15

0.021

PDLIM5

PDZ and LIM domain 5

0.15

0.004

ENO3

enolase 3

0.15

0.002

MYLPF

myosin light chain, phosphorylatable, fast skeletal muscle

0.15

0.013

AK1

adenylate kinase 1

0.15

0.002

MYH1A

myosin, heavy chain 1 A, skeletal muscle

0.14

0.007

DMD

dystrophin

0.13

0.002

LAMA2

laminin, alpha 2

0.13

0.003

GATM

glycine amidinotransferase

0.13

0.002

FABP1

fatty acid binding protein 1

0.12

0.000

ANKRD2

ankyrin repeat domain 2

0.11

0.003

MYH13

myosin, heavy chain 13, skeletal muscle

0.11

0.004

MYH15

myosin, heavy chain 15

0.10

0.000

MYL2

myosin, light chain 2, regulatory, cardiac, slow

0.10

0.003

MYSC

myosin heavy chain, cardiac muscle isoform

0.10

0.000

ADPRHL1

ADP-ribosylhydrolase like 1

0.10

0.007

MYOZ2

myozenin 2

0.10

0.000

FBP2

fructose-1,6-bisphosphatase 2

0.09

0.027

SRCA

sarcalumenin

0.09

0.002

XIRP1

xin actin-binding repeat containing 1

0.09

0.002

ATP2A1

ATPase, Ca++ transporting, cardiac muscle, fast twitch 1

0.08

0.000

TMOD4

tropomodulin 4

0.08

0.022

TNNI2

troponin I type 2

0.08

0.001

AMPD1

adenosine monophosphate deaminase 1

0.06

0.052

MYOM1

myomesin 1

0.06

0.020

APOBEC2

apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2

0.05

0.010

CAMSAP1

calmodulin regulated spectrin associated protein 1

0.04

0.003

TNNT3

troponin T type 3

0.04

0.004

CASQ2

calsequestrin 2

0.04

0.009

MYOZ1

myozenin 1

Table 4. Differentially expressed proteins in abdominal adipose tissue of FO vs. CO chicks at 14 d. FO/CO
ratio is the ratio of normalized protein abundance in abdominal adipose tissue at 14 d from N = 3 samples per
diet group; CO, corn oil; FO, fish oil. P-values are from T-tests, FO vs. CO. *Included to show trend because of
potential biological relevance.
that regulates cell fate in the developing embryo through epigenetic modification46. Expression of APOBEC2 is
primarily associated with skeletal muscle, in which it is linked to myoblast differentiation, but it is also expressed
in adipose tissue in chickens47. If maternal FO feeding reduced adiposity through epigenetic mechanisms, which
are often stable it has important implications for new means to control childhood (and potentially adult) obesity.
Follow-on studies to characterize methylation patterns and other epigenomic marks of maternal FO feeding are
needed to explore this possibility.
Chickens provide a unique means to address maternal programming by dietary fatty acids, but several caveats
and limitations should be noted. Fish oil and CO were the primary sources of dietary fatty acids in our model.
This was intentional, to maximize enrichment of the yolk in EPA and DHA. However, fatty acid consumption in
human diets is more diverse and complex, and the level of enrichment we achieved may not occur in the context
of a typical human diet. Nevertheless, our results provide proof-of-principle that fatty acids provided prior to
birth regulate adipose development. As such, they contribute additional rationale for further studies in humans
to determine if maternal fatty acid intake can be used to reduce the risk of childhood obesity. Intake of most fish
species during pregnancy is now encouraged by the U.S. Food and Drug Administration, easing previous concerns about safety of fish oil intake through foods48. Our study was also limited to measuring adiposity within a
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GO Enrichment
ID

Term

Count Adj. P-value

GO:0007010

Cytoskeleton organization

11

1.16 × 10−6

GO:0030049

Muscle filament sliding

7

3.85 × 10−6

GO:0006094

Gluconeogenesis

5

3.49 × 10−3

GO:0007517

Muscle organ development

6

3.31 × 10−3

GO:0007017

Microtubule-based process

4

3.26 × 10−2

GO:0006928

Movement of cell or subcellular component

5

3.26 × 10−2

KEGG Pathway
ID

Pathway

Count Adj. P-value

04530

Tight junction

7

0.0052

00010

Glycolysis/gluconeogenesis

5

0.0297

Table 5. Functional enrichment of differentially abundant proteins in adipose tissue of chicks produced from
hens fed diets containing CO or FO for 28 d. The set of differentially abundant proteins in adipose tissue at
14 d was functionally annotated using the Functional Annotation and Pathway Mapping options in DAVID
(v 6.8). ID refers to the specific GO term or KEGG pathway. Count represents the number of differentially
abundant proteins that are annotated with each GO term or are components of each KEGG pathway; CO, corn
oil; FO, fish oil. Adj. P-value represents the P-value for overrepresentation of GO terms or KEGG pathways after
adjusting for false discovery using Bonferroni correction.

short period (up to 14 days) after hatch, so the longevity of reduced fatness is unknown. Recent studies linking
maternal levels of EPA and DHA during pregnancy with child fatness at up to six years of age encourage the interpretation that the programming effects of FO may persist. It should also be noted that, although our focus herein
was on adipose tissue, it is reasonable to expect that development of other tissues could have been affected by
maternal FO consumption. This is particularly possible for bone, muscle and cartilage, which arise from the same
progenitor cell population as adipocytes. Further studies with in depth characterization of body composition will
be necessary to explore potential additional effects of maternal fish oil consumption on development.
Similarities and differences in metabolism between chickens and humans should also be noted. In both
species, liver is the primary site of de novo lipogenesis49,50, which contrasts with rodents and swine51,52.
Transcriptomic studies of chicken adipose tissue in several labs, including ours, have shown that many of the
genes involved in fat deposition in humans are differentially expressed between lean and fat lines of chickens53–56.
For example, genes involved in adipogenesis, de novo lipogenesis, and triglyceride synthesis are upregulated in
chickens with relatively high levels of adiposity. The various lean and fat model pairs used in these studies arose
from different methods (e.g., phenotypic selection for abdominal fat54, growth rate55, feed efficiency56, and use in
production53), indicating the robustness of these gene-phenotype relationships. A notable metabolic difference
between chickens and humans is that chickens are naturally hyperglycemic compared to mammals, although regulation of insulin release and pancreatic β cell function are similar57–59. Insulin signaling is attenuated in skeletal
muscle and adipose tissue (but not liver60,61). Accordingly, chickens are considered as a model of early insulin
resistance that may be relevant for studies of diabetes in humans61.An ortholog of the leptin gene was not identified in the first few annotations of the chicken genome, which raised questions about potential differences in
adipose biology between the two species62. Recently, however, improved annotation and sequencing of GC-rich
regions led to characterization of chicken leptin, as well as orthologs of other mammalian genes that are expressed
in adipose tissue63,64.
In summary, our data demonstrate that maternal fish oil consumption reduces adipose deposition in offspring. Our study was limited to the first two weeks of life, and follow-on experiments are necessary to determine
how long this effect persists as chicks mature. These results complement recent studies in humans that link LC n-3
PUFA in the maternal diet to reduced adipose mass in children. Accordingly, they highlight the potential to attenuate fat accumulation and potentially the risk for childhood obesity through dietary intervention prior to birth.

Methods

Diets and husbandry.

Animal husbandry procedures were reviewed and approved by the Institutional
Animal Care and Use Committees of the University of Georgia (broiler breeder hens) and the University of
Tennessee (chicks), and all methods were performed according to relevant guidelines and regulations of these
two institutions. Cobb 500 broiler breeder hens were maintained at the University of Georgia. For 28 d, hens
(N = 30/diet) were fed broiler breeder diets that were supplemented with either CO (Conagra Brands; Chicago
IL) or FO (Jedwards International, Braintree MA). This specific source of FO was produced from anchovies and
contained 18% EPA and 12% DHA. The two diets were prepared by adding either CO or FO (2.3% wt:wt) to a
commercially-formulated broiler-breeder diet consisting primarily of corn and soybean meal. Formulas for each
diet are shown in Supplemental Table 2. The final fat content of the two diets was 5.8%, with 49.7% (CO) and
43.6% (FO) from n-6 of fatty acids, and 2.2% (CO) and 5.2% (FO) from n-3 fatty acids. Fatty acid composition
of each diet is shown in Supplemental Table 3. After feeding hens for 28 d, fertilized eggs were collected from
each hen and transported to the University of Tennessee for incubation and hatching. Multiple roosters were
used for fertilization of eggs in each diet group. Eggs were weighed and incubated for three weeks, until hatch.
Hatch rates were calculated for each group as a percentage of eggs that produced viable chicks. At hatch, chicks
were grouped by hen diet (CO or FO) and housed separately in brooder cages (n = 10/cage) at standard brooding
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temperature 35 °C. Each cage was equipped with a feeder and drinker to which birds had ad libitum access. All
chicks (both CO and FO) were fed a standard broiler starter diet in which added fat (3% fat wt:wt) was supplied
from CO, using the same source of oil that was used to prepare the hen CO diet. Weight gain and feed intake were
monitored weekly.

Blood and tissue collection. Chicks were euthanized by CO2 asphyxiation. Two chicks from each
group were euthanized at hatch for collection of liver and brain for lipid analyses. Samples of each tissue were
snap-frozen and stored at −80 °C. The remaining chicks were euthanized at 7 and 14 d of age. At the time of
euthanasia blood was collected by cardiac venipuncture and transferred to 10 ml serum separator tubes (Fisher
Scientific, Pittsburgh, PA). Serum was separated by centrifugation and stored at −80 °C until analyses of circulating metabolites. Abdominal and femoral (subcutaneous) adipose depots were dissected and weighed as indices
of adiposity. Samples of each depot and of liver were subsequently snap-frozen in liquid nitrogen and stored at
−80 °C. Samples of abdominal adipose tissue were fixed for 24 h at 4 °C in paraformaldehyde (4%) for determination of adipocyte size by histology.
Serum metabolites.

Commercially available colorimetric assay kits were used to measure serum glucose (Cayman Chemical, Ann Arbor, MI) and non-esterified fatty acid (NEFA) levels (Wako Chemicals, Neuss,
Germany).

Fatty acid analysis. Abdominal fat samples from five randomly selected birds in each diet and age were analyzed for fatty acid composition by GC with flame ionization detection (GC-FID) by the W.M. Keck Metabolomics
Research Laboratory (Iowa State University, Des Moines, IA).. Tissues were pulverized under liquid nitrogen
using a stainless steel mortar and pestle. Approximately 100 mg of pulverized tissue was weighed from each bird
and extracted in glass vials in chloroform:methanol (2:1). Extracted fats were trans-esterified with sodium methoxide. The fatty acid methyl esters (FAMES) were extracted into hexane and analyzed using an Agilent 7890 A
GC-FID, with Agilent CP-Wax 52CB column (15 m, 0.32mm, 0.5um; Agilent, Santa Clara, CA). The oven starting
temperature of 100 °C, increased to 170 °C with a ramp of 2 °C/min, increased to 180 °C with a ramp of 0.5°C/
min, to a final temperature of 250°C with a ramp of 10°C/min. A mix of FAME standards (Supelco 37 FAME mix;
catalog # CRM47885 SUPELCO, Bellefonte, PA) was used to generate a calibration curve for identification and
quantification of FAMES. Data for each fatty acid were expressed as mole% ± SEM. The activities of stearoyl-CoA
desaturase (SCD) and delta-6 desaturase (D6D), and indices of de novo lipogenesis (DNL) and elongation (EL)
were estimated from mole% values using the following equations: 1.) SCD-16: 16:1n-7/16:0; 2.) SCD-18: 18:1n9/18:0; 3.) D6D: 18:3n-6/18:2n-6; 4.) DNL: 16:0/18:2n-6; 5.) EL: 18:0/16.
Phospholipid analysis.

Fatty acid composition of phosphatidylcholine species in brain and liver collected
at hatch (n = 2/diet) and in abdominal adipose tissue collected at 7 d of age (n = 5/diet) was analyzed using
UltraHigh Performance Liquid Chromatograph (UHPLC)-MS (Thermo-Fisher Scientific, Waltham, MA). Tissue
samples (100 mg) were pulverized under liquid nitrogen using a mortar and pestle. Phospholipids were extracted
using a modified Bligh and Dyer protocol65. Dried extracts were resuspended in 300μL of methanol/chloroform
(9:1) for UHPLC-MS analysis as previously described66. Lipid species were identified using exact m/z and retention times. Lipid standards (Avanti Polar Lipids, Alabaster AL) from each phospholipid class were run to verify
retention times. All ion fragmentation was used to confirm that phosphatidylcholines contained DHA and EPA
as acyl chains. For all ion fragmentation scans, the resolution was 140,000 with a scan range of 100-1500 m/z.
The normalized collision energy was 30 eV with a stepped collision energy of 50%. Lipids were identified by their
fragments using Xcalibur software (Thermo Fisher Scientific, San Jose, CA). Data analysis was performed using
Maven software67.

Adipocyte size. Abdominal fat samples from three birds per diet at each of the two ages were embedded,
sectioned and stained with hematoxylin and eosin (H&E; two slides/bird) for determination of adipocyte size, as
previously described by53. The three birds with adiposity values closest to the median adiposity within each diet/
age group were used. Briefly, images of three independent fields per slide were captured on each slide under 20x
magnification with the Advanced Microscopy Group EVOS XL Core microscope (Fisher Scientific, Pittsburgh,
PA). For consistency, the same person performed all measurements. Image J (Version 1.48, National Institutes of
Health) was used to determine adipocyte area, (μm2), using microscope settings of 2.8 μm/pixel, and using the
restriction that measurements must exceed 500 μm2. Frequency distributions were produced by grouping adipocytes into bins based on area and counting the frequency of cells within each bin. A standard method was used to
calculate adipocyte volume and number68.
Real time PCR assay. Total RNA was isolated from approximately 200 mg of abdominal adipose tissue and
liver from five chicks at 14 d in each diet group using InvitrogenTM TRIzolTM (Invitrogen, Carlsbad, CA). The five
birds with adiposity values closest to the median adiposity within each diet were used. CDNA was synthesized
from 500 ng total RNA in 20 μl reactions using iScript cDNA Synthesis kit (Bio-Rad Laboratories, Hercules,
CA). Predesigned and validated primers for quantitative real-time PCR (QPCR) were purchased from Qiagen
(Quantitect; Germantown, MD). QPCR was performed in triplicate for each sample using iQ SYBR Green Master
Mix (Bio-Rad Laboratories, Hercules, CA), as previously described53. Expression levels of genes of interest were
normalized to expression of TBC1 domain family, member 8 (TBC1D8) used as a housekeeper.
Proteomics. Approximately one g of abdominal adipose tissue from each of three chicks per diet was pulverized in liquid nitrogen, of which approximately 60 mg was used for protein extraction. Proteins were extracted
using a detergent-free, methanol/chloroform (2:1) protein extraction protocol69 designed for lipid-rich tissues
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and based on the Bligh and Dyer method70. Proteins were precipitated from the aqueous fraction using trichloroacetic acid and digested with sequencing grade trypsin. Approximately two mg of proteolytic peptides were
obtained from each sample after clean up. Fifty µg aliquots of these peptides were used for 2D-LC-MS/MS proteomic measurements on an LTQ Orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham, MA), as
previously described71. MyriMatch v2.1.11172 was used to search the raw mass spectra against the predicted protein database to identify fully-tryptic peptides, which were then grouped together into respective proteins with
IDPicker v.373. Only protein identifications with at least two identified peptide spectra and a maximum q-value of
0.02 were considered for further analysis. Peptide fragments were mapped to proteins in the Gallus gallus genome
(V3.0) using Uniprot.

Statistical Analysis. Statistical analyses were performed using SAS (V 9.4). Data were checked for normality
using Shapiro-Wilks prior to statistical testing. Body and adipose weights, serum metabolites, tissue fatty acid
composition, average adipocyte size and adipocyte number were analyzed using mixed model ANOVA with
terms for diet, age and their interaction (diet X age). Significant F-tests (P < 0.05) were followed by post-hoc
testing using least square means (LSM) to identify pairwise differences between groups. The frequencies of adipocytes within each bin at each age, as well as QPCR data, were compared between CO and FO using independent t-tests. Proteins that differed in abundance between CO and FO adipose tissue were also identified by
t-test after protein spectral counts were log-transformed and pareto-scaled in MetaboAnalyst 3.074 to normalize
data distributions. Functional analysis of differentially abundant proteins was performed using the Functional
Annotation and Pathway Mapping options found in the Database for Annotation, Visualization and Integrated
Discovery (DAVID, V 6.8)75. All statistical tests were performed using P-values ≤ 0.05 as the criterion for statistical significance.
Data availability.

The datasets generated during the current study are available from the corresponding
author on reasonable request
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